Target intelligence / Profile preview

ADP-ribosylation factor GTPase-activating protein 1 (ARFGAP1)

Target
ARFGAP1
Molecular classification
Enzyme, GTPase-activating protein, Regulatory protein
01

Overview

ADP-ribosylation factor GTPase-activating protein 1 (ARFGAP1) is an enzyme that functions as a GTPase-activating protein (GAP) for ADP-ribosylation factor 1 (ARF1) and can also act on ARF-like protein Arl1[2][3][4][5]. ARFGAP1 is primarily localized to the Golgi apparatus, where it regulates vesicle trafficking by stimulating the hydrolysis of GTP bound to ARF1, leading to coat protein dissociation from Golgi-derived membranes—an essential step for vesicle fusion with target compartments[2][3][5][6][8]. The activity of ARFGAP1 is modulated positively by phosphoinositides and inhibited by phosphatidylcholine. The protein contains amphipathic lipid packing sensor motifs (ALPS), which enable it to sense membrane curvature and vesicle maturity[3]. Through its function, ARFGAP1 is a key regulator of protein and membrane transport in the early secretory pathway and the structure of the Golgi apparatus[3][5][8]. Although associated with some disease phenotypes such as cataracts, there is limited evidence for direct therapeutic targeting, interacting drugs, or use as a clinical biomarker[5].

Other names
ARF GTPase activating protein 1ARF1GAPARF GAP 1ARF1 GAPFLJ10767bA261N11.3ADP-ribosylation factor 1 GTPase-activating proteinARF1-directed GTPase-activating proteinHRIHFB2281
02

Biological functions

Membrane traffickingVesicle transportRegulation of ARF1 GTPase activityGolgi apparatus structure and functionPromotes GTP hydrolysis for ARF1 and Arl1Coat protein dissociation from Golgi-derived vesicles
03

Disease associations

Cataract (reported association)Other (potential roles in vesicle trafficking-related disorders, but limited direct disease linkage reported)

Beyond the preview

Go deeper on ADP-ribosylation factor GTPase-activating protein 1 (ARFGAP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ADP-ribosylation factor GTPase-activating protein 1 (ARFGAP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call